MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$9,512K
Net Income
-$3,782K
Net Profit Margin
-39.76%
Unit: Thousand (K) dollars
Revenue Breakdown
Consumables Revenue
Capital Revenue
Engineering Revenue
Product And Service Other
Revenue Breakdown
Therapeutics
Diagnostics
Development Services
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net revenue
9,512
8,799
10,471
8,095
Cost of revenue
3,471
3,315
3,301
2,659
Gross profit
6,041
5,484
7,170
5,436
General and administrative
5,379
5,413
6,172
5,900
Research and development
1,070
1,154
1,643
1,784
Selling and marketing
3,675
3,817
4,519
4,358
Impairment expense
-
-
0
-
Loss from operations
-4,083
-4,900
-5,164
-6,606
Interest income
404
455
515
561
Loss on disposal of assets
-2
-15
-25
-36
Other expense
-43
-26
-48
-13
Foreign exchange (loss) income
-15
-9
-22
-46
Loss before income taxes
-3,739
-4,495
-4,744
-6,140
Income tax expense (benefit)
26
39
-214
-19
Net loss
-3,765
-4,534
-4,530
-6,121
Unrealized loss, change in fair value of available-for-sale securities, net of tax
-5
-43
-8
34
Change in foreign currency translation
-12
-14
-25
-18
Net loss and comprehensive loss
-3,782
-4,591
-4,563
-6,105
Basic EPS
0
0
-0.005
-0.01
Diluted EPS
-
0
-0.005
-0.01
Basic Average Shares
979,949,668
979,949,668
979,949,668
979,949,668
Diluted Average Shares
-
-
979,949,668
979,949,668
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
ZOMDF Income Statement Sankey Diagram
Sankey diagram visualizing ZOMDF income statement for the period
Net loss and
comprehensive loss
-$3,782K
(48.57%↑ Y/Y)
Therapeutics
$5,112K
Diagnostics
$1,175K
Development Services
$362K
Therapeutics
$1,626K
Diagnostics
$210K
Development Services
$3K
Revenue From Contract
With Customer...
$979K
Development Services
$29K
Therapeutics
$16K
Net loss
-$3,765K
(49.11%↑ Y/Y)
Change in foreign
currency translation
-$12K
(-121.82%↓ Y/Y)
Unrealized loss, change in
fair value of...
-$5K
(50.00%↑ Y/Y)
Consumables Revenue
$6,649K
Capital Revenue
$1,839K
Engineering Revenue
$979K
Product And Service
Other
$45K
Loss before income
taxes
-$3,739K
(49.38%↑ Y/Y)
Income tax expense
(benefit)
$26K
(116.67%↑ Y/Y)
Interest income
$404K
(-35.77%↓ Y/Y)
Net revenue
$9,512K
(36.59%↑ Y/Y)
Loss from operations
-$4,083K
(49.18%↑ Y/Y)
Gross profit
$6,041K
(29.47%↑ Y/Y)
Other expense
-$43K
(-10.26%↓ Y/Y)
Foreign exchange (loss)
income
-$15K
(-125.86%↓ Y/Y)
Loss on disposal of
assets
-$2K
(-300.00%↓ Y/Y)
Cost of revenue
$3,471K
(51.04%↑ Y/Y)
General and
administrative
$5,379K
(-12.71%↓ Y/Y)
Selling and marketing
$3,675K
(-21.02%↓ Y/Y)
Research and development
$1,070K
(-43.27%↓ Y/Y)
Buy us a coffee
Zomedica Corp. (ZOMDF)
Zomedica Corp. (ZOMDF)